Moreover, CSF, but not serum GFAP, correlated with albumin quotient (Qalb) in relapsing and progressive MS patients (Spearman rho = 0.3 and 0.4 respectively, p = 0.02 for both). Here, GFAP is linked to myeloid sarcoma.